ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

Clovis Oncology 

1871 Folsom Street

Boulder  Colorado  80302  U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS








 Company News
Clovis Oncology (CLVS) Release: Initial Data From Ongoing Phase 2 ARIEL2 Study Of Rucaparib In Ovarian Cancer Demonstrate Encouraging Clinical Activity And Safety In Both BRCA Mutant And Brcaness Patients 11/20/2014 9:21:39 AM
Clovis Oncology (CLVS) Release: Interim Data From Rociletinib (CO-1686) Phase 1/2 Study Shows Compelling And Durable Clinical Activity And Progression-Free Survival (PFS) In Patients With EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) 11/19/2014 12:14:36 PM
Clovis Oncology (CLVS) Rises On News Of GlaxoSmithKline (GSK) Oncology Collaboration 11/18/2014 7:59:35 AM
Clovis Oncology (CLVS) Announces First Patient Enrolled In TIGER-1 Study 11/13/2014 10:53:56 AM
Clovis Oncology (CLVS) Announces Third Quarter 2014 Operating Results 11/7/2014 9:14:33 AM
Clovis Oncology (CLVS) To Present At The 2014 Credit Suisse Healthcare Conference 11/5/2014 9:56:10 AM
Clovis Oncology (CLVS) Announces First Patient Enrolled In Lucitanib Phase 2 Study In Squamous Non-small Cell Lung Cancer 10/24/2014 11:19:43 AM
Clovis Oncology (CLVS) To Announce Third Quarter 2014 Financial Results And Host Webcast Conference Call On November 6 10/22/2014 9:54:18 AM
Tiny Clovis Oncology (CLVS) Races With AstraZeneca PLC (AZN) To Develop Lung Cancer Drug 10/2/2014 6:11:31 AM
Clovis Oncology (CLVS) Release: Data From Ongoing Phase 2 Studies Of Rucaparib In Ovarian Cancer Demonstrate Safety And Clinical Activity, Validate Differentiated Strategy 9/29/2014 2:11:24 PM
12345678910